How High Will Take-Two Stock Go?
Take-Two Interactive (NASDAQ:TTWO) is the video game development company behind…
Sell
28
HSTM Quote, Financials, Valuation and Earnings
Last price:
$26.60
Seasonality move
:
0.57%
Day range:
$25.72 - $27.67
52-week range:
$25.72 - $34.24
Dividend yield:
0.44%
P/E ratio:
42.22x
P/S ratio:
2.78x
P/B ratio:
2.24x
Volume:
708.1K
Avg. volume:
251.8K
1-year change:
-3.55%
Market cap:
$812M
Revenue:
$291.6M
EPS (TTM):
$0.63
Analysts' Opinion
-
Consensus RatingHealthStream has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $34.50, HealthStream has an estimated upside of 29.7% from its current price of $26.60.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $29.00 representing 100% downside risk from its current price of $26.60.
Fair Value
-
According to the consensus of 5 analysts, HealthStream has 29.7% upside to fair value with a price target of $34.50 per share.
HSTM vs. S&P 500
-
Over the past 5 trading days, HealthStream has underperformed the S&P 500 by -2.95% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
HealthStream does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthStream has grown year-over-year revenues for 17 quarters straight. In the most recent quarter HealthStream reported revenues of $73.5M.
Earnings Growth
-
HealthStream earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter HealthStream reported earnings per share of $0.14.
Enterprise value:
698.7M
EV / Invested capital:
--
Price / LTM sales:
2.78x
EV / EBIT:
34.97x
EV / Revenue:
2.39x
PEG ratio (5yr expected):
4.90x
EV / Free cash flow:
20.21x
Price / Operating cash flow:
23.53x
Enterprise value / EBITDA:
11.33x
Gross Profit (TTM):
$193.6M
Return On Assets:
3.75%
Net Income Margin (TTM):
6.54%
Return On Equity:
5.39%
Return On Invested Capital:
5.39%
Operating Margin:
5.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $270.4M | $282.9M | $292.4M | $72.8M | $73.5M | |
| Gross Profit | $177.4M | $187.1M | $193.6M | $48.1M | $48M | |
| Operating Income | $11.3M | $18.8M | $20M | $5.7M | $4.4M | |
| EBITDA | $49.9M | $60.3M | $61.6M | $16M | $15.1M | |
| Diluted EPS | $0.39 | $0.58 | $0.63 | $0.17 | $0.14 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $115M | $107.2M | $125.1M | $147.4M | $169.7M | |
| Total Assets | $501.7M | $483.9M | $503.2M | $511.6M | $524M | |
| Current Liabilities | $116.9M | $114.6M | $121M | $126.1M | $125.9M | |
| Total Liabilities | $164.9M | $161.4M | $167.1M | $166.8M | $161.2M | |
| Total Equity | $336.8M | $322.6M | $336M | $344.9M | $362.8M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $51.1M | $64.4M | $63.8M | $20.9M | $27.1M | |
| Cash From Investing | -$41.3M | -$46.8M | -$34.1M | -$7.1M | -$7.2M | |
| Cash From Financing | -$4.3M | -$14M | -$4.8M | -$1.7M | -$2M | |
| Free Cash Flow | $24.5M | $37M | $34.6M | $13.2M | $18.2M | |
HSTM
Sector
Market Cap
$812M
$32.8M
Price % of 52-Week High
77.69%
46.34%
Dividend Yield
0.44%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
-3.55%
-35.67%
Beta (5-Year)
0.432
0.632
Dividend yield:
0.44%
Annualized payout:
$0.11
Payout ratio:
18.3%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$27.45
200-day SMA
Sell
Level
$30.78
Bollinger Bands (100)
Sell
Level
28.68 - 33.42
Chaikin Money Flow
Buy
Level
14M
20-day SMA
Sell
Level
$27.85
Relative Strength Index (RSI14)
Sell
Level
33.10
ADX Line
Sell
Level
23.88
Williams %R
Neutral
Level
-73.6132
50-day SMA
Sell
Level
$29.59
MACD (12, 26)
Sell
Level
-0.59
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Neutral
Level
22.7M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (4.93)
Buy
CA Score
(Annual)
Level (0.8358)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-1.3553)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
Stock Forecast FAQ
In the current month, HSTM has received 2 Buy ratings 3 Hold ratings, and 0 Sell ratings. The HSTM average analyst price target in the past 3 months is $34.50.
-
Where Will HealthStream Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthStream share price will rise to $34.50 per share over the next 12 months.
-
What Do Analysts Say About HealthStream?
Analysts are divided on their view about HealthStream share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthStream is a Sell and believe this share price will drop from its current level to $29.00.
-
What Is HealthStream's Price Target?
The price target for HealthStream over the next 1-year time period is forecast to be $34.50 according to 5 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is HSTM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthStream is a Hold. 3 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HSTM?
You can purchase shares of HealthStream via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthStream shares.
-
What Is The HealthStream Share Price Today?
HealthStream was last trading at $26.60 per share. This represents the most recent stock quote for HealthStream. Yesterday, HealthStream closed at $26.60 per share.
-
How To Buy HealthStream Stock Online?
In order to purchase HealthStream stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Target’s Stock Be in 10 Years?
If you could hop into a time machine and land…
Why Did Stan Druckenmiller Buy DocuSign?
Billionaire Stanley Druckenmiller’s Duquesne Family Office portfolio is always worth…
Stock Ideas
Buy
64
Is MSFT Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 40x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
37
RGC alert for Jun 21
Regencell Bioscience Holdings [RGC] is down 40.02% over the past day.
Buy
83
GMS alert for Jun 21
GMS [GMS] is up 23.79% over the past day.
Buy
57
QNTM alert for Jun 21
Quantum BioPharma [QNTM] is up 13.82% over the past day.
